SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,000 | -4.3% | 300 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $23,000 | -14.8% | 300 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $27,000 | -3.6% | 300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $28,000 | +21.7% | 300 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $23,000 | +4.5% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $22,000 | -56.9% | 300 | 0.0% | 0.01% | -58.8% |
| Q4 2020 | $51,000 | +21.4% | 300 | 0.0% | 0.02% | +6.2% |
| Q3 2020 | $42,000 | -12.5% | 300 | 0.0% | 0.02% | -20.0% |
| Q2 2020 | $48,000 | +65.5% | 300 | 0.0% | 0.02% | +33.3% |
| Q1 2020 | $29,000 | -23.7% | 300 | 0.0% | 0.02% | -11.8% |
| Q4 2019 | $38,000 | +65.2% | 300 | 0.0% | 0.02% | +41.7% |
| Q3 2019 | $23,000 | -50.0% | 300 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $46,000 | -23.3% | 300 | -40.0% | 0.02% | -22.6% |
| Q1 2019 | $60,000 | +11.1% | 500 | 0.0% | 0.03% | -3.1% |
| Q4 2018 | $54,000 | -33.3% | 500 | 0.0% | 0.03% | -25.6% |
| Q3 2018 | $81,000 | – | 500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |